CAMK2G and heart failure: Moreover, treatment with GS-680 improved cellular Ca homeostasis in cardiomyocytes from patients with end-stage heart failure, showing that CaMKII inhibition is also a promising therapeutic concept in human ventricular cardiac tissue [22].